title: Data safety monitoring boards and other study methodologies that address subject safety in "high-risk" therapeutic trials in youths.
authors.affiliation: Drs. Carandang, Carrey, Gardner, and Kutcher are with the Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada; Dr. Santor is with the School of Psychology, University of Ottawa, Ottawa, Ontario, Canada. Electronic address: carlo.carandang@iwk.nshealth.ca.
authors.forename: Carlo
authors.initials: C
authors.lastname: Carandang
authors.affiliation: Drs. Carandang, Carrey, Gardner, and Kutcher are with the Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada; Dr. Santor is with the School of Psychology, University of Ottawa, Ottawa, Ontario, Canada.
authors.forename: Darcy
authors.initials: D
authors.lastname: Santor
authors.affiliation: Drs. Carandang, Carrey, Gardner, and Kutcher are with the Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada; Dr. Santor is with the School of Psychology, University of Ottawa, Ottawa, Ontario, Canada.
authors.forename: David M
authors.initials: DM
authors.lastname: Gardner
authors.affiliation: Drs. Carandang, Carrey, Gardner, and Kutcher are with the Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada; Dr. Santor is with the School of Psychology, University of Ottawa, Ottawa, Ontario, Canada.
authors.forename: Normand
authors.initials: N
authors.lastname: Carrey
authors.affiliation: Drs. Carandang, Carrey, Gardner, and Kutcher are with the Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada; Dr. Santor is with the School of Psychology, University of Ottawa, Ottawa, Ontario, Canada.
authors.forename: Stan
authors.initials: S
authors.lastname: Kutcher
mesh_terms: D000293:Adolescent; D002648:Child; D026661:Clinical Trials Data Monitoring Committees; D002986:Clinical Trials as Topic; D003511:Cyclohexanols / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D003865:Major Depressive Disorder / Q000188:drug therapy*; D064420:Drug-Related Side Effects and Adverse Reactions; D023381:Endpoint Determination / Q000009:adverse effects*; D005260:Female; D006805:Human Experimentation; D006801:Humans; D008297:Male; D012107:Research Design; D012307:Risk Factors; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D013406:Suicide, Attempted; D016896:Treatment Outcome; D000069470:Venlafaxine Hydrochloride
chemical_list: D003511:Cyclohexanols; D003692:Delayed-Action Preparations; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride